Metronidazole 500 Mg Tablets Suppliers & Bulk Manufacturers
Available Forms: Oral Tablets and Capsules
Available Strengths: 250 mg, 500 mg
Reference Brands: Flagyl(US), Metron (India)
Category:
Medical Aid
Metronidazole inhibits bacterial and protozoal DNA synthesis by disrupting nucleic acid structure. It effectively treats anaerobic infections, including abscesses, pelvic inflammatory disease, and protozoal infections. Benefits include rapid bacterial eradication, good tissue penetration, and oral convenience, making it a reliable option for treating various anaerobic and parasitic infections.
Metronidazole 500 mg Tablets is available in Oral Tablets and Capsules
and strengths such as 250 mg, 500 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Metronidazole 500 mg Tablets is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Metronidazole 500 mg Tablets can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Metronidazole tablets are approved in the EU and US for anaerobic bacterial and protozoal infections. In the EU, brands like Flagyl are regulated by EMA, supported by dossiers demonstrating safety, efficacy, and manufacturing standards. In the US, FDA approval relies on extensive clinical data, with generic options widely available. Both regions require detailed dossiers, including clinical trial results, quality assurance, and pharmacovigilance plans for approval and ongoing safety. For expert regulatory support, dossier preparation, and compliance, visit PharmaTradz. We facilitate seamless market access for metronidazole tablets, ensuring adherence to European and US standards for safe, effective antimicrobial therapy.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing